HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization.
about
OPV strains circulation in HIV infected infants after National Immunisation Days in Bangui, Central African Republic.Safety of licensed vaccines in HIV-infected persons: a systematic review protocol.Guidance on vaccination of HIV-infected children in Europe.B cells in HIV infection and diseaseAssessment of the epidemiology and burden of measles in Southern Mozambique.Impaired humoral response to vaccines among HIV-exposed uninfected infants[Booster doses outside of the Expanded Program on Immunization in two schools in basic education in Yaounde, Cameroon].Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients.Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy.Role of IL-21 and IL-21 receptor on B cells in HIV infection.Whole-cell pertussis vaccine induces low antibody levels in human immunodeficiency virus-infected children living in sub-Saharan Africa.Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adultsLong-term immune responses to vaccination in HIV-infected patients: a systematic review and meta-analysis.Measles and Rubella Seroprevalence Among HIV-infected and Uninfected Zambian Youth.T cell anergy and activation are associated with suboptimal humoral responses to measles revaccination in HIV-infected children on anti-retroviral therapy in Nairobi, Kenya.Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children.Immune responses to oral poliovirus vaccine in HIV-exposed uninfected Zimbabwean infants.
P2860
Q33581150-FB856ABC-AA66-4CFC-9057-61FBCD5808ACQ34178074-9DF8D3A1-6B9E-4521-B87D-69E0E84A124FQ34251138-D3818747-DF2E-447A-932C-D5257BCE9752Q34605780-97E1C988-A7F3-4C3A-98F6-57B086833A2BQ35065640-4CD461D4-B4CD-4251-B163-68711A9CDD27Q35191100-504C6F76-73B0-4EF4-BB08-918962AF40C5Q35573079-D19E65E2-F939-4422-965E-F09D5543004FQ35887330-02FE505F-5D43-42FE-BAE3-8C94F0AE2FB8Q36379247-69971827-F112-4A9D-867E-916608F8A389Q36670538-D3BA2884-2645-4D8F-B546-18F0D30717B8Q37156766-E2B55E2E-0782-4485-9286-92957C9E9C76Q37168665-CF0D23BA-12DC-4120-A6F7-93F70822A9E5Q38177767-70CA68A6-8EEC-48AA-B67A-41AFE4210148Q39159372-11EC8347-4A1A-48D0-9DAA-B69D0BD29367Q41295794-124525CB-B794-4C39-9327-7A64E0A7AECBQ45103186-6FF9FFE9-2FBD-466D-870E-531B82F60C9CQ47131363-E94FD979-17F2-4118-9E95-0521F38E7882
P2860
HIV-infected children living in Central Africa have low persistence of antibodies to vaccines used in the Expanded Program on Immunization.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
HIV-infected children living i ...... anded Program on Immunization.
@ast
HIV-infected children living i ...... anded Program on Immunization.
@en
HIV-infected children living i ...... anded Program on Immunization.
@nl
type
label
HIV-infected children living i ...... anded Program on Immunization.
@ast
HIV-infected children living i ...... anded Program on Immunization.
@en
HIV-infected children living i ...... anded Program on Immunization.
@nl
prefLabel
HIV-infected children living i ...... anded Program on Immunization.
@ast
HIV-infected children living i ...... anded Program on Immunization.
@en
HIV-infected children living i ...... anded Program on Immunization.
@nl
P2093
P2860
P50
P1433
P1476
HIV-infected children living i ...... anded Program on Immunization.
@en
P2093
Catherine Bilong
Elisabeth Njamkepo
Gilbert Tene
Ionela Gouandjika
Jean C Gody
Lydie Béniguel
Marie-Claire Endegue Zanga
Mathurin C Tejiokem
Régis Pouillot
P2860
P356
10.1371/JOURNAL.PONE.0001260
P407
P577
2007-12-05T00:00:00Z